Celsion Scream Higher; Breaks Through Resistance

Shares of Celsion CLSN are moving higher today; currently, shares are up by 9.78%, trading at $3.48. The stock has been consolidating below the 20-day and 50-day moving averages for the past few weeks; CLSN has now firmly broken through those resistance levels. Celsion now needs to consolidate around the $3.50 level. If shares are not sold off from these levels, they could trade fairly quickly to the $4.00 level. If shares were to drift lower, the 20 and 50-day moving averages will now act as support (and favorable stop loss levels). Note that Celsion has 3.94% short interest. Celsion Corporation is an oncology drug development company focused on improving treatment for those suffering with aggressive and difficult to treat forms of cancer.